Thomas E. Renau

1.2k total citations
29 papers, 942 citations indexed

About

Thomas E. Renau is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Thomas E. Renau has authored 29 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Organic Chemistry and 8 papers in Epidemiology. Recurrent topics in Thomas E. Renau's work include Synthesis and Biological Evaluation (10 papers), Antibiotic Resistance in Bacteria (8 papers) and Cancer therapeutics and mechanisms (5 papers). Thomas E. Renau is often cited by papers focused on Synthesis and Biological Evaluation (10 papers), Antibiotic Resistance in Bacteria (8 papers) and Cancer therapeutics and mechanisms (5 papers). Thomas E. Renau collaborates with scholars based in United States and Japan. Thomas E. Renau's co-authors include Roger Léger, Ving J. Lee, Suzanne Chamberland, Toshiharu Ohta, Kiyoshi Nakayama, Eric M. Flamme, Olga Lomovskaya, Rose Yen, John C. Drach and Joan Sangalang and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Thomas E. Renau

29 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas E. Renau United States	15	502	471	270	244	232	29	942
Peter Angehrn Switzerland	22	603 1.2×	515 1.1×	536 2.0×	246 1.0×	451 1.9×	53	1.5k
Son T. Nguyen United States	13	534 1.1×	419 0.9×	224 0.8×	107 0.4×	302 1.3×	21	1.1k
Hideyuki Fukuda Japan	17	585 1.2×	451 1.0×	526 1.9×	305 1.3×	100 0.4×	32	1.1k
S. Pearson United States	8	388 0.8×	348 0.7×	174 0.6×	119 0.5×	187 0.8×	9	895
Franck Danel Switzerland	14	591 1.2×	490 1.0×	265 1.0×	147 0.6×	227 1.0×	17	1.0k
Alain Bonnefoy France	18	326 0.6×	554 1.2×	403 1.5×	412 1.7×	458 2.0×	26	1.3k
Roger Léger United States	16	981 2.0×	735 1.6×	443 1.6×	246 1.0×	253 1.1×	19	1.6k
Barbara A. Pelak United States	14	241 0.5×	329 0.7×	302 1.1×	180 0.7×	175 0.8×	28	939
Yoshikuni Onodera Japan	16	439 0.9×	356 0.8×	219 0.8×	211 0.9×	59 0.3×	20	833
Phaik‐Eng Sum United States	19	682 1.4×	534 1.1×	496 1.8×	161 0.7×	290 1.3×	32	1.5k

Countries citing papers authored by Thomas E. Renau

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Renau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Renau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Renau more than expected).

Fields of papers citing papers by Thomas E. Renau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Renau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Renau. The network helps show where Thomas E. Renau may publish in the future.

Co-authorship network of co-authors of Thomas E. Renau

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Renau. A scholar is included among the top collaborators of Thomas E. Renau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Renau. Thomas E. Renau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Sang Hyuck, Tina M. Woo, Shirin Arastu‐Kapur, et al.. (2011). Potent Inhibition of Multiple Proteasome Subunits by Carfilzomib in Multiple Myeloma and Solid Tumor Patients. Blood. 118(21). 5068–5068. 1 indexed citations

Watkins, William J., Rémy C. Lemoine, Lee S. Chong, et al.. (2004). Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure–activity relationships of (N-methyl-piperazinyl)-containing derivatives. Bioorganic & Medicinal Chemistry Letters. 14(20). 5133–5137. 13 indexed citations

Renau, Thomas E.. (2004). The potential of phosphodiesterase 4 inhibitors for the treatment of depression: opportunities and challenges.. PubMed. 5(1). 34–9. 25 indexed citations

Nakayama, Kiyoshi, Yohei Ishida, Masami Ohtsuka, et al.. (2003). MexAB-OprM-Specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: Discovery and early strategies for lead optimization. Bioorganic & Medicinal Chemistry Letters. 13(23). 4201–4204. 66 indexed citations

Nakayama, Kiyoshi, Yohei Ishida, Masami Ohtsuka, et al.. (2003). MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds. Bioorganic & Medicinal Chemistry Letters. 13(23). 4205–4208. 48 indexed citations

Watkins, William J., Roger Léger, Thomas E. Renau, et al.. (2003). The relationship between physicochemical properties, In vitro activity and pharmacokinetic profiles of analogues of diamine-Containing efflux pump inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(23). 4241–4244. 64 indexed citations

Renau, Thomas E., Roger Léger, Eric M. Flamme, et al.. (2003). Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorganic & Medicinal Chemistry Letters. 13(16). 2755–2758. 76 indexed citations

Renau, Thomas E., Roger Léger, Rose Yen, et al.. (2002). Peptidomimetics of Efflux Pump Inhibitors Potentiate the Activity of Levofloxacin in Pseudomonas aeruginosa. Bioorganic & Medicinal Chemistry Letters. 12(5). 763–766. 60 indexed citations

Renau, Thomas E., Roger Léger, Eric M. Flamme, et al.. (2001). Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorganic & Medicinal Chemistry Letters. 11(5). 663–667. 50 indexed citations

10.

Renau, Thomas E., Roger Léger, Eric M. Flamme, et al.. (1999). Inhibitors of Efflux Pumps in Pseudomonas aeruginosa Potentiate the Activity of the Fluoroquinolone Antibacterial Levofloxacin. Journal of Medicinal Chemistry. 42(24). 4928–4931. 219 indexed citations

11.

Jacobson, Jennie G., Thomas E. Renau, Mahmoud Nassiri, et al.. (1999). Nonnucleoside Pyrrolopyrimidines with a Unique Mechanism of Action against Human Cytomegalovirus. Antimicrobial Agents and Chemotherapy. 43(8). 1888–1894. 22 indexed citations

12.

Renau, Thomas E., Linda L. Wotring, John C. Drach, & L. B. TOWNSEND. (1996). ChemInform Abstract: Synthesis of Non‐Nucleoside Analogues of Toyocamycin, Sangivamycin, and Thiosangivamycin: Influence of Various 7‐Substituents on Antiviral Activity.. ChemInform. 27(23). 5 indexed citations

13.

Klopman, Gilles, et al.. (1996). N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies. Antimicrobial Agents and Chemotherapy. 40(11). 2637–2643. 17 indexed citations

14.

Renau, Thomas E., Linda L. Wotring, John C. Drach, & Leroy B. Townsend. (1996). Synthesis of Non-nucleoside Analogs of Toyocamycin, Sangivamycin, and Thiosangivamycin: Influence of Various 7-Substituents on Antiviral Activity. Journal of Medicinal Chemistry. 39(4). 873–880. 24 indexed citations

15.

Renau, Thomas E., Christopher Kennedy, Roger G. Ptak, et al.. (1996). Synthesis of Non-nucleoside Analogs of Toyocamycin, Sangivamycin, and Thiosangivamycin: The Effect of Certain 4- and 4,6-Substituents on the Antiviral Activity of Pyrrolo[2,3-d]pyrimidines. Journal of Medicinal Chemistry. 39(18). 3470–3476. 30 indexed citations

16.

Renau, Thomas E., et al.. (1995). Effect of Lipophilicity at N-1 on Activity of Fluoroquinolones against Mycobacteria. Journal of Medicinal Chemistry. 38(15). 2974–2977. 34 indexed citations

17.

KRAWCZYK, S. H., Thomas E. Renau, Mahmoud Nassiri, et al.. (1995). Synthesis and Evaluation of Certain Thiosangivamycin Analogs as Potential Inhibitors of Cell Proliferation and Human Cytomegalovirus. Journal of Medicinal Chemistry. 38(20). 4115–4119. 12 indexed citations

18.

Renau, Thomas E., et al.. (1994). Relationship between cytotoxicity and conversion of thiosangivamycin analogs to toyocamycin analogs in cell culture medium. Biochemical Pharmacology. 48(4). 801–807. 10 indexed citations

19.

Renau, Thomas E., Mahmoud Nassiri, Eric E. Swayze, et al.. (1992). Improved synthesis and biological evaluation of an acyclic thiosangivamycin active against human cytomegalovirus. Antiviral Research. 19(1). 15–28. 11 indexed citations

20.

Renau, Thomas E., et al.. (1991). Synthesis and biological evaluation of an acyclic thiosangivamycin. Antiviral Research. 15. 47–47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact